Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
Launched by HACETTEPE UNIVERSITY · Oct 31, 2021
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
The study was planned, and ethical approval procedures were initiated in late January, 2021. However, serial official approval processes delayed the initiation of the study beyond the pre-planned initiation date (late in March 2021, to catch the 28th day after the second dose of CoronaVac vaccine). Thus, the study plan was revised, and so were the approval processes.
The planned prospective cohort study started its recruitment process in June, with the first enrollment on June 21, 2021. The study is an open cohort; vaccination times vary, some students participated in the first visit, but ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) students of the medical school (grades 4,5 and 6) in 2021 Spring semester 2 )students of the dental school (grades 4 and 5) in 2021 Spring semester 3) new comers of grade 4 of medical and dental school in 2021 Fall semester 4) those providing informed consent to participate in the study.
- Exclusion Criteria:
- • None.
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Banu Cakir
Study Director
Hacettepe University, Division of Epidemiology (Chair)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials